Guides
Step therapy explained: "fail first" rules and how to get an exception
Step therapy requires you to try cheaper drugs before the plan covers a prescribed one; many states and plans let your doctor ask for an exception.
Step therapy, sometimes called "fail first," is a plan rule that requires you to try one or more lower-cost drugs, often generics, before the plan will cover the drug your doctor prescribed. If the first-step drugs do not work or cause problems, the plan moves you up a step. You can ask for an exception if you have already tried the step drugs, if they are likely to be harmful or ineffective for you, or if you are stable on the prescribed drug. Many states have laws that require plans to have an exception process with set response times, and the process is usually started by your prescriber.
How step therapy works
A plan's formulary lists the drugs it covers. For some drugs, the plan attaches a condition: before it pays for drug B, you must have tried drug A. The rule is a form of utilization management and is often combined with prior authorization, meaning your doctor sends records showing you meet the step requirement. The steps are usually set by the plan or its pharmacy benefit manager, using clinical guidelines and cost.
A typical sequence has two or three steps:
- A generic or low-cost drug that is widely used for the condition.
- A second, possibly brand-name, drug if the first fails or is not tolerated.
- The prescribed drug, which the plan covers only if the earlier steps were unsuccessful.
Step therapy appears most with drugs for chronic conditions, such as autoimmune disease, diabetes, migraine and mental health conditions, and with high-cost specialty drugs.
The case for and against
Plans and their supporters say step therapy steers patients to effective, lower-cost options first and keeps premiums down. Patient groups and many physician organizations say it can delay effective treatment, force a stable patient to switch, or require a patient to repeat a drug that already failed. Because the debate is active, rules differ widely between states and between plan types.
What counts as having tried a step drug
Plans generally accept:
- Records showing you used the step drug for an adequate time and it did not work.
- Records of an adverse reaction or side effect.
- A contraindication, meaning a medical reason the step drug is unsafe for you.
- Evidence that you tried the drug under a previous plan. Many plans accept pharmacy or doctor records from earlier coverage.
How long is "adequate" depends on the drug and the plan's criteria, so ask the plan for its written criteria. They are available to you on request.
How to ask for an exception
- Find out which step applies. The denial or the pharmacy's rejection message says the drug needs step therapy and often names the step drug.
- Ask your prescriber to request an exception. Many plans have a form, and it is often submitted through the plan's or PBM's portal.
- Give a clinical reason. The strongest reasons are a past trial with the step drug, a documented reaction, a medical reason that the step drug would be ineffective or harmful for you, being stable on the current drug, or a time-sensitive condition.
- Note the response time. Plans generally have a limited time to answer. Urgent requests, where a delay could seriously harm your health, get faster decisions, often within 24 to 72 hours depending on the plan and state.
- If denied, appeal. A step therapy exception denial can be appealed internally like other denials, and external review may be available. See how to appeal a denied health insurance claim, step by step.
Ask whether your state has a step therapy law. The state insurance department can say, and it may apply only to fully insured plans, not to self-funded employer plans, which follow federal rules (ERISA). Medicare Part D plans have their own exception process, run through the plan's coverage determination procedure.
A worked example with round numbers
This is an illustration. Say a plan covers a $500-per-month brand drug only after the patient has tried a generic costing $15 per month. The patient's doctor prescribes the brand drug because the patient took the generic for three months last year, under a previous plan, without relief. The doctor submits the pharmacy and visit records with an exception request. If the plan accepts those records, it approves the brand drug. If it says it cannot find the earlier trial, the doctor can send the old plan's pharmacy printout. If the plan still denies it, the patient files an internal appeal with the doctor's letter and asks for an expedited review if the delay is harming the patient. Without an exception, the patient would have to repeat the generic first, and the plan's decision timeline would pause the brand drug in the meantime.
What to do while you wait
- Ask the prescriber whether a temporary supply, a sample or a manufacturer's program is appropriate. Whether and which are available depends on the drug and your coverage.
- Ask the plan whether a transition or emergency supply is available, which some plans provide for drugs you were already taking.
- Compare the cost of paying cash for the step drug, which is often a generic with a low price.
- Keep copies of every request and decision.
See what to do when your plan will not cover a drug you need for the wider set of options, and how prior authorization works and what to do when it is denied for the approval process step therapy often travels with.
Key takeaways
- Step therapy requires a trial of cheaper drugs before the plan covers the prescribed one.
- Prior trials, side effects, medical contraindications and stability on a drug are common grounds for an exception.
- Your prescriber normally files the exception request, and the plan must answer within a set time.
- Many states regulate step therapy for fully insured plans, but self-funded plans follow federal rules.
- If an exception is denied, you can appeal and, in many cases, seek external review.